Bound to. The earnings reports prove RNVA does not belong in 000s. The OTC market is full of momentum traders who follow price movements on PR and MA rumors. I'm more interested in value. I've picked a few 000 winners by finding value the OTC market overlooked. I saw some value in DPLS held patents with the stock at .0001-.0002 for example, when the company had little revenue to show for them. The federal CAH designation was the overlooked value I saw in RNVA, and still do, but now the earnings reports are speaking for themselves. Value investors do go bottom fishing from time to time, they'll come along. Investors closer to the health care industry probably already have their eyes on the stock and the company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.